| 1 |
Ilango Subramanian |
Somerset Therapeutics |
12 |
| 1 |
Veerappan Subramanian |
Somerset Therapeutics |
12 |
| 3 |
Peter Clemente |
Gaf Energy |
6 |
| #4 |
Bruce Bier |
Richards Mfg. Co., A New Jersey Limited Partnership |
3 |
| #4 |
Zhu Chen |
Adimab |
3 |
| #4 |
Mazin Gilbert |
AT&T |
3 |
| #4 |
Hemant Thombre |
Nasdaq |
3 |
| #8 |
Hung Mach |
Pharmadesign |
2 |
| #9 |
Ling Tong |
Merck |
1 |
| #9 |
Raissa Trend |
— |
1 |
| #9 |
Kevin Fung |
JPMorgan Chase |
1 |
| #9 |
Akshina Gupta |
X Development |
1 |
| #9 |
Kevin Xu |
Emc Ip Holding Company |
1 |
| #9 |
Christine Drumheller ANDREWS |
Haleon Us Holdings |
1 |
| #9 |
Xianhai Huang |
Merck |
1 |
| #9 |
Sriman BANERJEE |
Glaxosmithkline Consumer Healthcare Holdings (Us) |
1 |
| #9 |
Jean Xu |
Bristol-Myers Squibb |
1 |
| #9 |
Dan Barber |
Aquestive Therapeutics |
1 |
| #9 |
David Ellis KELLSTEIN |
Haleon Us Holdings |
1 |
| #9 |
Bonny Rene Shaw |
Haleon Us Holdings |
1 |
| #9 |
Christopher E. HENRY |
— |
1 |
| #9 |
Mark Salacinski |
Bristol-Myers Squibb |
1 |
| #9 |
Peter Boyd |
Aquestive Therapeutics |
1 |
| #9 |
Jianhong Qiu |
Colgate-Palmolive |
1 |
| #9 |
João Carlos Falcão SARDINHA |
— |
1 |
| #9 |
Theresa Wood |
Aquestive Therapeutics |
1 |
| #9 |
John Maxwell |
Power-One |
1 |
| #9 |
Keith Kendall |
Aquestive Therapeutics |
1 |
| #9 |
Simon Bernard Abtalion |
JPMorgan Chase |
1 |